Production and properties of monoclonal antibodies to guinea pig Ia antigens
- PMID: 6190070
- DOI: 10.1016/0076-6879(83)92010-4
Production and properties of monoclonal antibodies to guinea pig Ia antigens
Abstract
Although the use of monoclonal antibodies to characterize the Ia antigen system is still in its infancy, the usefulness of this approach is clearly apparent. Since xenogeneic immunization can be used to generate these antibodies, the chances are good that a greater variety of Ia types and determinants will be detected compared to those detected with conventional alloantisera. In addition, the advantages of unlimited quantity and constant specificity allow a much greater degree of standardization than was previously possible. Finally, monoclonal antibodies open up lines of investigation, such as the examination of correlations between the monoclonal antibody's inhibition of T-cell proliferation and the antibody's corresponding Ia epitope-binding characteristics, that it would be impossible to approach using conventional alloantisera.
Similar articles
-
Monoclonal antibodies directed against human Ia antigens detect an evolutionary conserved epitope on guinea pig Ia antigens with unique functional properties.J Leukoc Biol. 1984 Jan;35(1):101-13. doi: 10.1002/jlb.35.1.101. J Leukoc Biol. 1984. PMID: 6200553
-
[Characterization of monoclonal antibodies to human Ia antigens].Allerg Immunol (Leipz). 1985;31(4):321-30. Allerg Immunol (Leipz). 1985. PMID: 2936223 German.
-
Non-activated guinea-pig T cells and thymocytes express Ia antigens: FACS analysis with alloantibodies and monoclonal antibodies.Immunology. 1984 Jan;51(1):93-102. Immunology. 1984. PMID: 6197362 Free PMC article.
-
The syngeneic mixed leukocyte reaction: an autoreactive self-renewing cellular network for mature T lymphocytes.Braz J Med Biol Res. 1986;19(1):1-9. Braz J Med Biol Res. 1986. PMID: 2432976 Review.
-
Purification of antigens and monoclonal antibodies.Clin Rheumatol. 1987 Jun;6 Suppl 1:43-55. doi: 10.1007/BF02200718. Clin Rheumatol. 1987. PMID: 3304799 Review. No abstract available.
Cited by
-
Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies.J Clin Invest. 1990 Dec;86(6):2136-44. doi: 10.1172/JCI114952. J Clin Invest. 1990. PMID: 2254463 Free PMC article. Clinical Trial.
-
Murine antiidiotypic monoclonal antibodies that bear the internal image of HLA-DR allospecificities.J Clin Invest. 1989 Sep;84(3):907-14. doi: 10.1172/JCI114252. J Clin Invest. 1989. PMID: 2474577 Free PMC article.
-
Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.J Clin Invest. 1991 Jan;87(1):284-92. doi: 10.1172/JCI114984. J Clin Invest. 1991. PMID: 1898655 Free PMC article.
-
Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma.Br J Cancer. 1996 Nov;74(10):1586-91. doi: 10.1038/bjc.1996.593. Br J Cancer. 1996. PMID: 8932339 Free PMC article.
-
Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA.J Clin Invest. 1993 Feb;91(2):684-92. doi: 10.1172/JCI116249. J Clin Invest. 1993. PMID: 8432869 Free PMC article.